US Patent Issued to aAb Therapeutics on Aug. 19 for "Compounds and methods for suppressing an immune response to substances containing polyethylene glycol" (Pennsylvania Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,485, issued on Aug. 19, was assigned to aAb Therapeutics LLC (Spring City, Pa.).

"Compounds and methods for suppressing an immune response to substances containing polyethylene glycol" was invented by Vidal F. de la Cruz (Phoenixville, Pa.) and Joseph M. Salvino (Chester Springs, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds, compositions and methods for suppressing an immune response to polyethylene glycol (PEG) are provided."

The patent was filed on Nov. 22, 2022, under Application No. 17/991,925.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2...